IP Library Granted Patent US 7,121,999
Granted Patent B2
US 7,121,999 · App. 10/378,483 · Granted Oct 17, 2006

Method of preparing layered graft prostheses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,121,999
App. No.
10/378,483
Granted
Oct 17, 2006
Kind
B2
Abstract

The invention is directed to bioengineered graft prostheses made from two or more superimposed, chemically bonded layers of processed tissue material prepared from cleaned tissue material derived from animal sources. The bioengineered graft prostheses of the invention are prepared using methods that preserve cell compatibility, strength, and bioremodelability of the processed tissue matrix. The bioengineered graft prostheses are used for implantation, repair, or for use in a mammalian host.

Claims (17)

1. The method of preparing a prosthesis having two or more superimposed, bonded layers of processed tissue matrix, comprising:

(a) layering two or more sheets of hydrated processed tissue matrix;

(b) dehydrating said layers to adhere the layers together;

(c) crosslinking said layers with a crosslinking agent to bond the layers together; and,

(d) rinsing said layers to remove the crosslinking agent;

wherein said thus formed prosthesis when implanted into a mammalian patient, undergoes controlled biodegradation occurring with adequate living cell replacement such that the original implanted prosthesis is remodeled by the patient's living cells,

wherein the processed tissue matrix is prepared by;

(e) mechanically cleaning the layers of tissue matrix and

(f) chemically cleaning the layers of tissue matrix,

wherein chemically cleaning the layers of tissue matrix comprises:

(g) contacting the tissue matrix with a chelating agent under alkaline conditions;

(h) contacting the tissue matrix with an acid containing a salt;

(i) contacting the tissue matrix with a buffered salt solution; and

(j) rinsing the tissue matrix.

2. The method of claim 1 , wherein the chelating agent comprises ethylenediaminetetracetic acid.

3. The method of claim 1 , wherein the acid containing a salt comprises hydrochloric acid containing sodium chloride.

4. The method of claim 1 , wherein the buffered salt solution comprises sodium chloride in phosphate buffered saline.

Assignments (4)
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT Recorded Aug 6, 2021
From: ORGANOGENESIS INC.
To: SILICON VALLEY BANK
Reel/Frame 057112/0677 →
SECURITY INTEREST Recorded Jun 19, 2018
From: ORGANOGENESIS INC.
To: SILICON VALLEY BANK
Reel/Frame 046392/0242 →
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2017
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: ORGANOGENESIS INC.
Reel/Frame 042072/0977 →
SECURITY AGREEMENT Recorded Sep 23, 2011
From: ORGANOGENESIS, INC.
To: WELLS FARGO BANK, N.A.
Reel/Frame 026954/0666 →